|
Re: 0.05 P-values -- A bridge too far ?
|
5
|
Resverlogix Corp.
|
Feb 13, 2020 10:24PM
|
|
A brief news piece dated yesterday...
|
3
|
Resverlogix Corp.
|
Feb 18, 2020 10:09PM
|
|
Re: Funny
|
2
|
Resverlogix Corp.
|
Mar 19, 2020 07:00PM
|
|
Re: QBI COVID-19 research results
|
13
|
Resverlogix Corp.
|
Apr 30, 2020 03:33PM
|
|
Re: CRISPR screen identifies COVID19 enabling genes
|
6
|
Resverlogix Corp.
|
Jun 24, 2020 04:41PM
|
|
Re: Still not finding on ClinicalTrials gov
|
4
|
Resverlogix Corp.
|
Apr 21, 2021 10:29PM
|
|
Re: Still not finding on ClinicalTrials gov
|
3
|
Resverlogix Corp.
|
Apr 23, 2021 01:28PM
|
|
Re: Trial Status
|
2
|
Resverlogix Corp.
|
Jul 20, 2021 12:55PM
|
|
Lets go science...
|
6
|
Resverlogix Corp.
|
Nov 02, 2022 12:42PM
|
|
Barron's rating; albeit a single analyst:
|
3
|
Resverlogix Corp.
|
Dec 06, 2022 01:05PM
|
|
Re: Barron's rating; albeit a single analyst:
|
4
|
Resverlogix Corp.
|
Dec 07, 2022 03:59PM
|
|
Recent article; published in Clinical Epigenetics
|
4
|
Resverlogix Corp.
|
Jan 13, 2023 01:29PM
|
|
Review article on epigenetics and references apabetalone a lot; exposure.
|
9
|
Resverlogix Corp.
|
Feb 06, 2023 10:48AM
|
|
Re: New Publication Conclusion
|
7
|
Resverlogix Corp.
|
Mar 01, 2023 12:43PM
|
|
Re: Anybody ever post this link already?
|
3
|
Resverlogix Corp.
|
Apr 14, 2023 12:30PM
|
|
Re: AGM
|
3
|
Resverlogix Corp.
|
Jun 06, 2023 10:02PM
|
|
Published today; data on apabetalone in CKD
|
6
|
Resverlogix Corp.
|
Jun 08, 2023 01:01PM
|
|
Recent publications:
|
11
|
Resverlogix Corp.
|
Sep 26, 2023 01:07PM
|
|
Re: Recent publications:
|
11
|
Resverlogix Corp.
|
Sep 28, 2023 01:13PM
|
|
Re: Long time that we’ve seen a post!
|
6
|
Resverlogix Corp.
|
Oct 20, 2023 01:22PM
|
